Here's a look at some of the top regulatory stories for medical device companies this week: Masimo reveals FDA warning letter over Pronto 7 monitor; FDA issues new draft guidance on Class III de novos, UDI for small entities; Medicare finalizes coverage for MitraClip
Masimo reveals FDA warning letter over Pronto 7 monitor
August 15, 2014 by Brad Perriello
Centers for Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), Masimo, Abbott Laboratories
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1oNAOeI
Cap comentari:
Publica un comentari a l'entrada